Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG

Director/PDMR Shareholding

30 Nov 2006 15:18

Synairgen plc30 November 2006 Synairgen plc ("Synairgen" or the "Company") Director Shareholdings The Company was informed on 30 November 2006 that Richard Marsden, ManagingDirector of Synairgen, had been granted options on 30 November 2006 over 70,606ordinary shares of 1 pence each ("Ordinary Shares") in the Company under theCompany's Long-Term Incentive Plan (the "LTIP") at an exercise price of 1 pence. Mr Marsden's holding in options over Ordinary Shares has therefore increased to814,435, representing approximately 3.75 per cent. of the issued ordinary sharecapital of the Company. The Company was informed on 30 November 2006 that John Ward, Finance Director ofSynairgen, had been granted options on 30 November 2006 over 128,484 OrdinaryShares in the Company under the Company's LTIP at an exercise price of 1 pence. Mr Ward's holding in options over Ordinary Shares has therefore increased to513,675, representing approximately 2.37 per cent. of the issued ordinary sharecapital of the Company. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Mar 20167:00 amRNSPositive LOXL2 results
3rd Mar 20167:00 amRNSNotice of Preliminary Results
16th Nov 20154:11 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
13th Nov 20153:08 pmRNSHolding(s) in Company
13th Nov 201511:41 amRNSHolding(s) in Company
13th Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSDirectors' Share Purchase
28th Oct 20157:00 amRNSGrant of options
16th Sep 20157:00 amRNSInterim Results
21st Aug 20157:00 amRNSNotice of Interim Results
5th Aug 20157:00 amRNSSynairgen announces research collaboration
22nd Jul 20157:00 amRNSAstraZeneca commences Phase II Trial
22nd Jun 20151:41 pmRNSResult of AGM
2nd Jun 20159:37 amRNSHolding(s) in Company
15th May 201511:04 amRNSNotice of AGM
22nd Apr 20155:03 pmRNSPosting of Annual Report and Accounts
5th Mar 201512:55 pmRNSRichard Griffiths increases stake to 6.1 percent
3rd Mar 20157:00 amRNSPreliminary Results
12th Feb 201512:44 pmRNSHolding(s) in Company
11th Nov 20142:34 pmRNSExercise of options
4th Nov 20147:00 amRNSGrant of Options
8th Oct 20147:00 amRNSExercise of options
25th Sep 20147:00 amRNSInterim results for the six months ended 30 June
17th Sep 20147:00 amRNSNotice of Interim Results
22nd Jul 20145:23 pmRNSHolding(s) in Company
22nd Jul 201411:11 amRNSHolding(s) in Company
22nd Jul 201411:08 amRNSHolding(s) in Company
21st Jul 20143:53 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSHolding(s) in Company
15th Jul 20143:13 pmRNSHolding(s) in Company
4th Jul 20142:44 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSPlacing
25th Jun 20147:00 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSLicence deal with AstraZeneca
9th Jun 20141:00 pmRNSResult of AGM
16th May 20147:00 amRNSNotice of AGM
9th May 20142:57 pmRNSNotice of Report and Accounts
20th Mar 20147:00 amRNSPreliminary Results
11th Mar 20145:05 pmRNSHolding(s) in Company
6th Mar 201412:58 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSLicensing Update, Placing & Notice of results
14th Oct 20139:05 amRNSExercise of Options
12th Aug 20137:00 amRNSHalf Yearly Report
18th Jul 20137:00 amRNSPositive anti-inflammatory and anti-viral data
3rd Jul 20133:05 pmRNSHolding(s) in Company
10th Jun 20131:45 pmRNSResult of AGM
21st May 201311:10 amRNSHolding(s) in Company
9th May 201312:45 pmRNSNotice of AGM
9th Apr 20134:26 pmRNSPosting of Annual Report
12th Mar 20137:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.